Recently large and exciting decisions have been made at ContextVision. From now on, [they] will focus our pathology business entirely on the establishment of an AI based pathology lab service, and are now in the process of moving the...

In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites. STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing...

STOCKHOLM – July 6, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that agreements to conduct a multicenter...

ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, has made a first on-site installation of a prototype version of INIFY™ Prostate, a sophisticated AI-based decision support tool,...